Login Here


Register
 


 Russell Publishing Ltd
 Court Lodge
 Hogtrough Hill
 Brasted
 Kent TN16 1NU. UK
 Registered in England 
 No. 2709148
 Registered office as above.
 VAT No. GB 577 897847

 

Antibody-based proteomics to study cellular signalling networks

publication date: Mar 19, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

The complexity of drug discovery faces many challenges; principally, the failure of drug candidates during the development process as a result of adverse effects or lack of efficacy.  A key reason for this high attrition rate is that we are only just beginning to understand the complexity of the response(s) from a biological system to perturbations, such as a disease state or drug treatment. Subsequently, a deeper insight into the molecular mechanisms underlying both disease processes and drug action will ultimately contribute to increased productivity through the drug discovery process.



Sorry, this page is available to members only.

If you have not registered with us yet, why not register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.

Why should I register online with European Pharmaceutical Review?

* To access past and current articles

* Add and view comments on articles

* View all the latest news